Numira Biosciences acquires Ricerca's Bothell lab operations
US-based Numira Biosciences has expanded its imaging and pre-clinical services portfolio after acquiring the efficacy pharmacology operating unit of Ricerca Biosciences.
Numira, which specialises in high resolution 3D imaging and visualisation software for the life science market, claim the Washington state site, located in Bothell, providesh a “state-of-the-art, GLP compliant facility, with a highly talented team and a broad range of laboratory capabilities.”
Michael Beeuwsaert, CEO of Numira said: “The Bothell site has a long-standing, strong reputation in the CRO market and possesses deep scientific expertise in several therapeutic areas that compliment Numira's imaging technology.
“By combining our respective strengths, we are well positioned to provide even greater value to both Numira's and Ricerca's clients and pursue new opportunities for growth.”
